3.200
+0,00%
2026-10-19
Fundamental Analysis
70 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +507.9% | +286.2% | 3 / 3 | -30.2% | +2.36 pp | +1.03 pp | +1.7% | 0.33 | 16.04 | 87,2 | −30,2% | 0,8 | +507,9% | 16.04 | 55.93 | −71,3% |
| Pts | 12 | 12 | 12 | 0 | 8 | 8 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 3.200 (close price on 2026-10-19)EPS (TTM): 199,5
Financial charts
1.Revenue & growth
VND bn87,1Q2/26
1.Revenue & growth
VND bn87,1Q2/26
2.Profit & growth
VND bn0,64Q2/26
3.Profit mix (Penman)
VND bn3,58Q2/26
4.Margins & cost structure
%1.3%Q2/26
5.Returns & cash cycle
% · days-1.2%Q2/26
6.Earnings quality & cash
VND bn6,97Q2/26
7.Asset structure
VND bn343Q2/26
8.Funding & debt health
VND bn · times343Q2/26
9.Revenue backlog
VND bn0,53Q2/26
10.Valuation
times · %16,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %41Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
175%
averaged over 2 quarter(s)
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26